期刊文献+

他克莫司胶囊微生物限度检查方法的建立 被引量:1

Establishment of the microbial limit verification test of tacrolimus capsules
下载PDF
导出
摘要 目的:建立他克莫司胶囊微生物限度检查方法。方法:参照《中国药典》(2015版)、《药品微生物检验手册》和《中国药品检验标准操作规范》(2010版)收载的微生物限度检验方法,建立他克莫司胶囊微生物限度检查方法。结果:实验证明采用薄膜过滤法对他克莫司胶囊进行微生物限度检查,能有效检出该药品中污染存活的细菌,检测后回收比值均在0.5~2范围内。结论:建立了适用于他克莫司胶囊微生物限度检验的薄膜过滤法,该法能有效地滤除药品中抑菌物质的干扰,其检出率高。 Objective:To establish the method of microbial limit test for tacrolimus capsules.Methods:The microbial limit verification test of tacrolimus capsules was established according to ChP 2015,Microbial Inspection Manual of Drugs and Standard Operation of Chinese Drug Inspection 2010.Results:The microbial limit verification test on tacrolimus capsules through membrane filtration method was carried out with the recovery rate between 0.5 and 2,which was proved to effectively detect the bacteria within the drugs.Conclusion:Microbial limit verification test of tacrolimus capsules through membrane filtration method was established with high detection rate,which can avoid antibacterial interference effectively.
作者 吴伟平 陈宇堃 梁蔚阳 余燕 WU Weiping;CHEN Yukun;LIANG Weiyang;YU Yan(Guangdong institute for Drug Control,Guangdong Food and Drug Administration Key Laboratory of Quality Control and Risk Assessment of Blood Products,Guangzhou 510663,China)
出处 《中国药品标准》 CAS 2020年第2期130-134,共5页 Drug Standards of China
基金 广东省医学科研基金(B2018130) 广州市科技计划项目(201804010251) 广东省食品药品管理局科技项目引导扶持基金(2018YDB02)。
关键词 他克莫司胶囊 微生物限度检查法 薄膜过滤法 Tacrolimus capsules microbial limit test membrane filtration method
  • 相关文献

参考文献6

二级参考文献40

  • 1龚伟,季曙明.他克莫司和环孢素A的疗效及其安全性比较[J].肾脏病与透析肾移植杂志,2005,14(3):285-289. 被引量:3
  • 2中国药典二部[S].2010年:附录Ⅵ.
  • 3Goto T, Kino T, Hatanaka H, et al. FK5116 : historical perspec- tives[J]. Transplant Proc, 1991,23(6) : 2713-2717.
  • 4Yamashita K, Nakate T, Okimoto K, et al. Establishment of new preparation method for solid dispersion formulation of ta- crolinms[J]. Int J Pharm, 2003,267 ( 1-2) : 79-91.
  • 5Constantinides PP. I.ipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmacemical aspects[J]. Pharm Res, 1995,12(11 ) : 1561-1572.
  • 6Li P, Ghosh A, Wagner RF, et al. Effect of combined use of nonionic surfactant on formation of oil in water microemulsions [J]. Int J Pharm, 2005,288 ( 1 ) : 27-34.
  • 7国家药典委员会.中华人民共和国药典(二部)2010版,北京:化学工业出版社,2006:附录107-116.
  • 8Abdul H M, Sama M A, Furman J L, et al. Cognitive decline in alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling[ J]. The Journal of Neuroscience, 2009, 29(41 ) :12 957 -12 969.
  • 9De Paulis A, Stellato C, Cirillo R, et al. Anti-Inflammato- ry effect of FK-506 on human skin mast cells [ J ]. Journal of investigative dermatology, 1992, 99(6) : 723 -728.
  • 10Paresh G, Vikas K, Parveen K, et al. Production of ta- crolimus (FK-506) using new streptomyces species: WO, 2005038009A2[P]. 2005 - 04 - 28.

共引文献85

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部